Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
In brief: This is a multicenter, randomized, non-comparative, phase II proof-of-concept trial involved patients with progressive vitiligo and uses one of the most common regimens in this phase of study. Assessment of the experimental treatment efficacy will be estimated only on the results obtained in the experimental treatment arm (baricitinib 4 mg/day + narrowband UVB TL01 arm).
Ages eligible: 18 Years to 75 Years
Start date: May 1, 2021
Completion date (estimated): November 30, 2023
Location: Hôpital Saint-André, Bordeaux, France
Status: Active, recruiting
Contact: To learn more about this study, you or your doctor may contact Dr. Julien SENESCHAL at +33 (0)5 56 79 47 05 or julien.seneschal@chu-bordeaux.fr
Please refer to this study by its ClinicalTrials.gov identifier NCT04822584
FAQOther Questions
- PTSD in Vitiligo?
Living with vitiligo often involves dealing with more than just skin changes. Many people with vitiligo face discrimination, social stigma, and isolation, which can lead to lowe...
- Pyrostegia venusta as a folk medicine for vitiligo?
Pyrostegia venusta is a neotropical evergreen vine widely spread in Brazil throughout fields, at the coast, edge of the woods and along roadsides (see photo below). Popularly kn...
- Which skin conditions can be mistaken for vitiligo?
Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.